Thyroid Therapy Could Enhance Gut Health in Hypothyroid Patients
New research indicates that treating hypothyroidism with thyroid hormones may reduce the risk of small intestinal bacterial overgrowth (SIBO), improving gut health and potentially impacting autoimmune disease prevention.
Recent research reveals a significant link between hypothyroidism and small intestinal bacterial overgrowth (SIBO), a condition characterized by excessive bacteria in the small intestine. The study, presented at ENDO 2025 by the Endocrine Society in San Francisco, highlights that individuals with an underactive thyroid are at a higher risk of developing SIBO, but this risk appears to decrease with effective thyroid hormone treatment.
Dr. Ruchi Mathur, a leading endocrinologist at Cedars-Sinai, explained that patients with autoimmune thyroid disease, especially hypothyroidism, are more susceptible to SIBO. The research indicates that thyroid medication, such as levothyroxine, may help mitigate this risk. The underlying mechanism might involve alterations in the gut microbiome related to thyroid hormone levels.
The study involved analyzing small bowel fluid samples from 49 hypothyroid patients and 323 controls. DNA sequencing revealed that 33% of hypothyroid individuals had SIBO compared to 15% of controls. Researchers further examined bacterial patterns in four groups divided by thyroid health and SIBO status, finding that gut bacteria compositions differ depending on these factors.
Additionally, large-scale analysis using the TriNetX database showed that people with hypothyroidism or autoimmune thyroiditis face 2.2 to 2.4 times higher risk of developing SIBO compared to controls. Importantly, patients on levothyroxine had a reduced risk, emphasizing the potential benefits of thyroid hormone therapy.
These insights suggest that enhancing thyroid health can improve gut microbiota balance, potentially reducing SIBO incidence. The findings advocate for more integrated monitoring of thyroid function and gut health, offering the possibility of personalized treatment approaches that could also impact autoimmune disease prevention, including Hashimoto’s thyroiditis.
As research continues, a better understanding of the microbiological mechanisms involved could lead to targeted therapies, helping at-risk populations maintain both thyroid and gut health.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Potential Impact of Trump Administration's Proposed Budget Cuts on Public Health and Medical Research
The Trump administration's proposed budget cuts threaten to significantly impair medical research, public health initiatives, and Medicaid, potentially slowing down medical progress and weakening healthcare systems in the US.
Gene Duplication in Fungus Causes Resistance, Hindering Treatment of Tropical Mycetoma
Recent research uncovers how gene duplication in Madurella fahalii leads to antifungal resistance, challenging current treatments for tropical mycetoma and guiding future drug development.
Older Maternal Age Linked to Increased Risks of Premature Birth and Complications in Newborns
New Swedish study shows that children born to mothers over 45 face higher risks of premature birth and complications, emphasizing the importance of informed pregnancy planning for older women.
Vitamin D Supplements May Slow Cellular Aging by Preserving Telomeres
New research shows that daily vitamin D supplements can help preserve telomere length, potentially slowing the biological aging process and reducing age-related disease risk.